70
Participants
Start Date
July 22, 2009
Primary Completion Date
May 22, 2018
Study Completion Date
May 22, 2018
CC-4047
0.5 mg capsules daily by mouth day 1 through day 28.
Prednisone
30 mg by mouth daily during cycle 1, 15 mg/day during cycle 2, and 15 mg every other day during cycle 3, and then it will be discontinued.
CC-4047
3.0 mg capsules daily by mouth day 1 through 21.
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Celgene
INDUSTRY
M.D. Anderson Cancer Center
OTHER